Adipokines: Deciphering the cardiovascular signature of adipose tissue

Biochem Pharmacol. 2022 Dec:206:115324. doi: 10.1016/j.bcp.2022.115324. Epub 2022 Oct 27.

Abstract

Obesity and hypertension are intimately linked due to the various ways that the important cell types such as vascular smooth muscle cells (VSMC), endothelial cells (EC), immune cells, and adipocytes, communicate with one another to contribute to these two pathologies. Adipose tissue is a very dynamic organ comprised primarily of adipocytes, which are well known for their role in energy storage. More recently adipose tissue has been recognized as the largest endocrine organ because of its ability to produce a vast number of signaling molecules called adipokines. These signaling molecules stimulate specific types of cells or tissues with many adipokines acting as indicators of adipocyte healthy function, such as adiponectin, omentin, and FGF21, which show anti-inflammatory or cardioprotective effects, acting as regulators of healthy physiological function. Others, like visfatin, chemerin, resistin, and leptin are often altered during pathophysiological circumstances like obesity and lipodystrophy, demonstrating negative cardiovascular outcomes when produced in excess. This review aims to explore the role of adipocytes and their derived products as well as the impacts of these adipokines on blood pressure regulation and cardiovascular homeostasis.

Keywords: Adipocytes; Adipose tissue; Blood pressure; Blood vessels.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / metabolism
  • Adipokines* / metabolism
  • Adipose Tissue / metabolism
  • Endothelial Cells* / metabolism
  • Humans
  • Leptin / metabolism
  • Obesity / metabolism

Substances

  • Adipokines
  • Leptin